State Street’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $204M | Buy |
|
|||||
|
2021
Q2 | $139M | Buy |
|
|||||
|
2021
Q1 | $135M | Sell |
|
|||||
|
2020
Q4 | $146M | Sell |
|
|||||
|
2020
Q3 | $129M | Buy |
|
|||||
|
2020
Q2 | $108M | Sell |
|
|||||
|
2020
Q1 | $133M | Buy |
|
|||||
|
2019
Q4 | $77.5M | Buy |
|
|||||
|
2019
Q3 | $56.2M | Sell |
|
|||||
|
2019
Q2 | $63.5M | Sell |
|
|||||
|
2019
Q1 | $85.7M | Buy |
|
|||||
|
2018
Q4 | $63.8M | Sell |
|
|||||
|
2018
Q3 | $88.6M | Buy |
|
|||||
|
2018
Q2 | $74.4M | Buy |
|
|||||
|
2018
Q1 | $57.3M | Buy |
|
|||||
|
2017
Q4 | $56.5M | Buy |
|
|||||
|
2017
Q3 | $41.5M | Sell |
|
|||||
|
2017
Q2 | $34.4M | Buy |
|
|||||
|
2017
Q1 | $27.4M | Buy |
|
|||||
|
2016
Q4 | $24.1M | Buy |
|
|||||
|
2016
Q3 | $32.1M | Buy |
|
|||||
|
2016
Q2 | $25.2M | Sell |
|
|||||
|
2016
Q1 | $22.5M | Buy |
|
|||||
|
2015
Q4 | $25.2M | Buy |
|
|||||
|
2015
Q3 | $8.34M | Buy |
|
|||||
|
2015
Q2 | $8.97M | Buy |
|
|||||
|
2015
Q1 | $9.34M | Buy |
|
|||||
|
2014
Q4 | $9.13M | Buy |
|
|||||
|
2014
Q3 | $6.51M | Sell |
|
|||||
|
2014
Q2 | $18.8M | Buy |
|
|||||
|
2014
Q1 | $3.71M | Buy |
|
|||||
|
2013
Q4 | $3.59M | Buy |
|